LANDSCAPE OF KRAS G12C MUTATIONS IN GENITOURINARY MALIGNANCIES

被引：0
|
作者：
Rebecca, Sager A.
Michael, Basin F.
Hanan, Goldberg
Jeffrey, Ross S.
Gennady, Bratslavsky
Joseph, Jacob M.
Petros, Grivas
Andrea, Necchi
机构：
[1] SUNY Upstate Med Univ, Syracuse, NY 13210 USA
[2] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA
[3] Univ Vita Salute San Raffaele, Milan, Italy
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2024年 / 42卷
关键词：
D O I：
10.1016/j.urolonc.2024.01.198
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
161
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [31] Differences in response to immunotherapy between KRAS G12C and KRAS non-G12C mutated NSCLC
    Pinto, L. Masfarre
    Rocha, P.
    Clave, S.
    Gorro, N. Navarro
    Sanchez, I.
    Giner, M.
    Lloret, A. Corbera
    Garcia, A. Taus
    Parreira, A. S. D. F. M.
    Paricio, B. Bellosillo
    Arriola, E.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S145 - S146
  • [32] Characterizing KRAS G12C and other mutations in plasma ctDNA from patients with lung cancer
    Murciano-Goroff, Yonina R.
    Lebow, Emily S.
    Tu, Hai-Yan
    Li, Mark
    Lim, Lee P.
    Arbour, Kathryn C.
    Travis, William
    Solit, David B.
    Ladanyi, Marc
    Jones, David R.
    Rudin, Charles M.
    Martinez, Andres
    Myers, Mackenzie L.
    Makhnin, Alexander
    Razavi, Pedram
    Offin, Michael D.
    Isbell, James W.
    Riely, Gregory J.
    Hyman, David M.
    Lito, Piro
    Li, Bob T.
    CLINICAL CANCER RESEARCH, 2020, 26 (12) : 24 - 24
  • [33] Association Between Histological Subtypes of Lung Adenocarcinoma and KRAS Mutations, with an Emphasis on G12C Mutations: A Pilot Study
    Keogh, A.
    O'Brien, C.
    Ward, R.
    Murchan, P.
    Baird, A. M.
    Gray, S. G.
    Finn, S. P.
    JOURNAL OF PATHOLOGY, 2022, 256 : S4 - S4
  • [34] Distribution of KRAS G12C somatic mutations in 41,913 Chinese cancer patients
    Zhang, Y.
    Li, X.
    Liu, C.
    Liu, R.
    Ma, T.
    ANNALS OF ONCOLOGY, 2021, 32 : S1220 - S1221
  • [35] Circulating Tumor DNA Dynamics Reveal KRAS G12C Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid Tumors
    Choi, Yoonha
    Dharia, Neekesh V.
    Jun, Tomi
    Chang, Julie
    Royer-Joo, Stephanie
    Yau, Kenneth K.
    Assaf, Zoe J.
    Aimi, Junko
    Sivakumar, Smruthy
    Montesion, Meagan
    Sacher, Adrian
    LoRusso, Patricia
    Desai, Jayesh
    Schutzman, Jennifer L.
    Shi, Zhen
    CLINICAL CANCER RESEARCH, 2024, 30 (17) : 3788 - 3797
  • [36] Diverse alterations associated with resistance to KRAS(G12C) inhibition
    Yulei Zhao
    Yonina R. Murciano-Goroff
    Jenny Y. Xue
    Agnes Ang
    Jessica Lucas
    Trang T. Mai
    Arnaud F. Da Cruz Paula
    Anne Y. Saiki
    Deanna Mohn
    Pragathi Achanta
    Ann E. Sisk
    Kanika S. Arora
    Rohan S. Roy
    Dongsung Kim
    Chuanchuan Li
    Lee P. Lim
    Mark Li
    Amber Bahr
    Brian R. Loomis
    Elisa de Stanchina
    Jorge S. Reis-Filho
    Britta Weigelt
    Michael Berger
    Gregory Riely
    Kathryn C. Arbour
    J. Russell Lipford
    Bob T. Li
    Piro Lito
    Nature, 2021, 599 : 679 - 683
  • [37] Clinical and Molecular profiling of KRAS G12C lung adenocarcinomas
    Bulusu, Venkata
    Jessop, Susan
    Paul, Sherin
    Chapman, Timothy
    Ben-Gashir, Mohamed
    Geetha, Anil
    Punnen, Geethu
    Aslam, Shahzeena
    Hutka, Margaret
    LUNG CANCER, 2023, 178 : S18 - S18
  • [38] The Research Progress of Direct KRAS G12C Mutation Inhibitors
    Yang, Ai
    Li, Min
    Fang, Mingzhi
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [39] KRAS G12C Inhibitors in the Treatment of Metastatic Colorectal Cancer
    Xiao, Annie
    Fakih, Marwan
    CLINICAL COLORECTAL CANCER, 2024, 23 (03) : 199 - 206
  • [40] Small Molecule Imaging Agent for Mutant KRAS G12C
    Koch, Peter D.
    Quintana, Jeremy
    Ahmed, Maaz S.
    Kohler, Rainer H.
    Weissleder, Ralph
    ADVANCED THERAPEUTICS, 2021, 4 (05)
12345